FAS Antibody

FAS Blocking/Activating antibody (CD95), Mouse anti Human
Cat. No.
BT4790
Source
Synonyms
FASLG receptor, Apoptosis-mediating surface antigen FAS, Apo-1 antigen, CD95, Tumor necrosis factor receptor superfamily member 6 TNR6, APT1, FAS1, TNFRSF6.
Appearance
Purity
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Product Specs

Introduction
The Fas receptor (CD95) is a key player in apoptosis, initiating programmed cell death upon binding with Fas-ligand (FasL) present on other cells. This Fas-FasL interaction is crucial for immune system regulation, particularly in eliminating self-reactive lymphocytes and preventing autoimmunity. Additionally, Fas signaling contributes to immune surveillance by targeting and eliminating transformed and virus-infected cells. The process begins when Fas binds to clustered FasL on another cell, activating apoptotic signaling through its cytoplasmic 'death domain'. This domain interacts with adaptor proteins like FAF, FADD, and DAX, setting off a cascade of caspase protease activation. Caspases 8 and 10 are activated first, followed by downstream caspases, which then break down various cellular components, ultimately leading to cell death. Notably, caspases target nuclear lamins, disrupting the nucleus's structure, and DNA fragmentation factor (DFF), causing DNA degradation. Other caspase substrates are involved in cytoskeletal organization, cell cycle control, and signaling pathways. Besides caspase activation, Fas-mediated apoptosis can also involve JNK kinase activation, Jun activation, and ceramide production. Conversely, proteins like I-FLICE and FAP can counteract Fas-mediated apoptosis. This system's importance is highlighted by the fact that viruses and tumors may evade immune responses by suppressing Fas-mediated apoptosis.
Formulation
Supplied as a 1 mg/ml solution in phosphate-buffered saline (PBS) after reconstitution.
Shipping Conditions
This antibody is shipped in lyophilized form at ambient temperature.
Storage Procedures
For long-term storage, keep the lyophilized antibody at 4°C in a dry environment. After reconstitution, it is recommended to aliquot and store the antibody at -20°C if not intended for use within one month.
Solubility
To reconstitute, add sterile water (H2O) to the vial. Mix gently by swirling, ensuring the solution reaches the sides of the vial, and allow 30-60 seconds for complete reconstitution before use.
Note
This antibody exhibits distinct functional properties depending on its state. In soluble form, it acts as a blocking antibody, inhibiting FAS-mediated apoptosis. However, when immobilized, it can activate FAS-mediated cell death.
Titer
Based on direct ELISA results, a 1:10,000 dilution of this antibody yields an optical density (O.D.) of 0.5 when using an alkaline phosphatase-conjugated rabbit anti-mouse immunoglobulin G (IgG) secondary antibody from Jackson Laboratories.
Synonyms
FASLG receptor, Apoptosis-mediating surface antigen FAS, Apo-1 antigen, CD95, Tumor necrosis factor receptor superfamily member 6 TNR6, APT1, FAS1, TNFRSF6.
Purification Method
Protein-A column.
Type
Mouse Anti Human Monoclonal.
Clone
NYRhFAS.
Immunogen
Recombinant Human FAS.
Ig Subclass
mouse IgG1.

Product Science Overview

Introduction

The FAS Blocking/Activating Antibody, also known as CD95, is a monoclonal antibody derived from mice and is specifically designed to target human FAS (CD95) proteins. This antibody plays a crucial role in the study of apoptosis, a form of programmed cell death, by either blocking or activating the FAS receptor.

FAS (CD95) Overview

FAS, also known as CD95 or APO-1, is a cell surface receptor that belongs to the tumor necrosis factor receptor superfamily. It is widely expressed on the surface of various cell types, including both normal and transformed cells. The primary function of FAS is to mediate apoptosis when it binds to its ligand, FASL (CD95L/Apo-1L). This interaction triggers a cascade of intracellular signaling events leading to cell death .

Mechanism of Action

The FAS Blocking/Activating Antibody can function in two distinct ways:

  1. Blocking: When in soluble form, the antibody can block the interaction between FAS and its ligand, thereby inhibiting the apoptotic signaling pathway. This is particularly useful in research focused on preventing cell death in various diseases.
  2. Activating: When immobilized, the antibody can mimic the action of FASL by binding to the FAS receptor and inducing apoptosis. This property is valuable in studies aimed at understanding the mechanisms of cell death and in developing therapies for conditions where inducing apoptosis is beneficial .
Applications

The FAS Blocking/Activating Antibody is utilized in a variety of research applications, including:

  • Direct ELISA: Used to detect and quantify the presence of FAS in samples.
  • Flow Cytometry: Employed to analyze the expression of FAS on the surface of cells.
  • Immunohistochemistry (IHC): Applied to visualize the distribution and localization of FAS in tissue sections.
  • Functional Assays: Used to study the effects of blocking or activating FAS-mediated apoptosis in cell cultures .
Storage and Stability

The antibody is typically shipped in a lyophilized form at ambient temperature. For long-term storage, it should be kept at -20°C. After reconstitution with water, it is recommended to aliquot and store the antibody at -20°C if not used within a month. Proper storage ensures the stability and efficacy of the antibody for up to 12 months .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.